Key facts
- Deep Track Capital, LP filed SCHEDULE 13G/A for Springworks Therapeutics, Inc. Common Stock, par value $0.0001 per share (SWTX).
- Disclosed ownership: 4.6%.
- Date of event: 31 Dec 2024.
Deep Track Capital, LP - 31 Dec 2024 SCHEDULE 13G/A Report for Springworks Therapeutics, Inc. Common Stock, par value $0.0001 per share (SWTX)
- Filing manager
- Deep Track Capital, LP
- Reporting owner
- Deep Track Capital, LP
- Symbol
- SWTX
- Shares outstanding
- 74,424,860 shares
- Disclosed shares
- 3,460,756 shares
- Ownership percentage
- 4.6%
- Form type
- SCHEDULE 13G/A
- Filing time
- 14 Feb 2025, 08:44:49 UTC
- Event date
- 31 Dec 2024
- SEC filing
- View on sec.gov
Reporting parties
Subject security
Ownership signal
SEC evidence
Key filing fact
Deep Track Capital, LP disclosed 4.6% ownership in Springworks Therapeutics, Inc. Common Stock, par value $0.0001 per share (SWTX) on 31 Dec 2024.
Change
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 14 Feb 2025, 08:44.
Research use
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Reporting managers (3)
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Deep Track Capital, LP | 4.6% | 3,460,756 | 0 | 3,460,756 | /s/ David Kroin | David Kroin, Managing Member of the General Partner of the Investment Adviser | |
| Deep Track Biotechnology Master Fund, Ltd. | 4.6% | 3,460,756 | 0 | 3,460,756 | /s/ David Kroin | David Kroin, Director | |
| David Kroin | 4.6% | 3,460,756 | 0 | 3,460,756 | /s/ David Kroin | David Kroin |
CIK / CUSIP context first